217 related articles for article (PubMed ID: 30622004)
1. Circulating tumor stem cells and glioblastoma: A review.
van Schaijik B; Wickremesekera AC; Mantamadiotis T; Kaye AH; Tan ST; Stylli SS; Itinteang T
J Clin Neurosci; 2019 Mar; 61():5-9. PubMed ID: 30622004
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Targeting of Cancer Stem Cells in Human Glioblastoma by Manipulating the Renin-Angiotensin System.
Tan DC; Roth IM; Wickremesekera AC; Davis PF; Kaye AH; Mantamadiotis T; Stylli SS; Tan ST
Cells; 2019 Oct; 8(11):. PubMed ID: 31683669
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
Chistiakov DA; Chekhonin VP
Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells.
Książkiewicz M; Markiewicz A; Zaczek AJ
Pathobiology; 2012; 79(4):195-208. PubMed ID: 22488297
[TBL] [Abstract][Full Text] [Related]
5. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
Mitra A; Mishra L; Li S
Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
[TBL] [Abstract][Full Text] [Related]
6. Mutual Influence of ROS, pH, and CLIC1 Membrane Protein in the Regulation of G
Peretti M; Raciti FM; Carlini V; Verduci I; Sertic S; Barozzi S; Garré M; Pattarozzi A; Daga A; Barbieri F; Costa A; Florio T; Mazzanti M
Mol Cancer Ther; 2018 Nov; 17(11):2451-2461. PubMed ID: 30135216
[TBL] [Abstract][Full Text] [Related]
7. Evidence for circulating cancer stem-like cells and epithelial-mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy.
Mirza S; Jain N; Rawal R
Tumour Biol; 2017 Mar; 39(3):1010428317695915. PubMed ID: 28347243
[TBL] [Abstract][Full Text] [Related]
8. Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.
Werner S; Stenzl A; Pantel K; Todenhöfer T
Adv Exp Med Biol; 2017; 994():205-228. PubMed ID: 28560676
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment.
Majc B; Sever T; Zarić M; Breznik B; Turk B; Lah TT
Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118782. PubMed ID: 32554164
[TBL] [Abstract][Full Text] [Related]
10. S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.
Chow KH; Park HJ; George J; Yamamoto K; Gallup AD; Graber JH; Chen Y; Jiang W; Steindler DA; Neilson EG; Kim BYS; Yun K
Cancer Res; 2017 Oct; 77(19):5360-5373. PubMed ID: 28807938
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells.
Koch K; Hartmann R; Schröter F; Suwala AK; Maciaczyk D; Krüger AC; Willbold D; Kahlert UD; Maciaczyk J
Oncotarget; 2016 Nov; 7(45):73414-73431. PubMed ID: 27705917
[TBL] [Abstract][Full Text] [Related]
12. Essentials of circulating tumor cells for clinical research and practice.
Liberko M; Kolostova K; Bobek V
Crit Rev Oncol Hematol; 2013 Nov; 88(2):338-56. PubMed ID: 23830807
[TBL] [Abstract][Full Text] [Related]
13. Plasticity in Glioma Stem Cell Phenotype and Its Therapeutic Implication.
Iwadate Y
Neurol Med Chir (Tokyo); 2018 Feb; 58(2):61-70. PubMed ID: 29129882
[TBL] [Abstract][Full Text] [Related]
14. USP18 regulates the malignant phenotypes of glioblastoma stem cells.
Li L; Yin Y; Zhang J; Wu X; Liu J; Chai J; Yang Y; Li M; Jia Q; Liu Y
Pathol Res Pract; 2023 Jul; 247():154572. PubMed ID: 37257245
[TBL] [Abstract][Full Text] [Related]
15. Brain malignancies: Glioblastoma and brain metastases.
Lah TT; Novak M; Breznik B
Semin Cancer Biol; 2020 Feb; 60():262-273. PubMed ID: 31654711
[TBL] [Abstract][Full Text] [Related]
16. Multilayered Heterogeneity of Glioblastoma Stem Cells: Biological and Clinical Significance.
Brown DV; Stylli SS; Kaye AH; Mantamadiotis T
Adv Exp Med Biol; 2019; 1139():1-21. PubMed ID: 31134492
[TBL] [Abstract][Full Text] [Related]
17. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.
Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G
J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263
[TBL] [Abstract][Full Text] [Related]
18. Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells.
Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
Adv Exp Med Biol; 2017; 994():247-254. PubMed ID: 28560678
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation.
Karsy M; Guan J; Jensen R; Huang LE; Colman H
World Neurosurg; 2016 Apr; 88():222-236. PubMed ID: 26724617
[TBL] [Abstract][Full Text] [Related]
20. Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells.
Micalizzi DS; Haber DA; Maheswaran S
Mol Oncol; 2017 Jul; 11(7):770-780. PubMed ID: 28544498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
